Tech-to-Market


Going to market with discoveries that matter

Why Commercialization Matters
Available Technologies

131

Invention Disclosures

FY 2024

54

Executed Licenses & Options

FY 2024

$7.8M

Licensing Revenue

FY 2024

Data Sources: Innovate Carolina Startups Database, UNC Office of Technology Commercialization, Association of University Technology Managers; UNC startups employment data (most recent analysis, July 2022)

Research discoveries that sit dormant on lab shelves don't do anyone any good. That's why Innovate Carolina's Office of Technology Commercialization team works closely with UNC-Chapel Hill researchers to take their scientific discoveries to market. Whether it's licensing Carolina-born technologies to industry or launching new startups, we find the smartest paths to human and economic impact.

Office of Technology Commercialization
Institute for Convergent Science
KickStart Venture Services

71

New Provisional Patent Applications

FY 2024

46

Issued U.S. Patents

FY 2024

8

IP-Based Startups Launched

FY 2024

UNC IP-Based Startups

0

Still Active

0

Headquartered in NC


Jobs Created by IP-Based Startups

0

Located in NC

0%

of active UNC IP-Based startups are headquartered in NC

Data Sources: Innovate Carolina Startups Database, UNC Office of Technology Commercialization, Association of University Technology Managers; UNC startups employment data (most recent analysis, FY 2024)

Go-to-market momentum

Carolina's commercialization impact

Cumulative

4,618

Invention Disclosures

1,898

New Provisional Patent Applications

1,366

Issued U.S. Patents

1,385

Executed Licenses & Options

$139.1M

Licensing Revenue

Health and life sciences. Our startup lifeblood.

90% of UNC-Chapel Hill's federal funding comes from four agencies: NIH, USAID, NSF and DHHS. This reflects the University's emphasis on health and life sciences programs and its outstanding schools of medicine, dentistry, pharmacy, nursing and public health. This foundation translates into strong life science-based startups that develop new therapeutics, diagnostics and medical devices aimed to create healthier outcomes for all.

$8.4B

in funding raised by UNC IP-based startups

(Since 1958)

$340M

in annual revenue earned by UNC IP-based startups

(FY 2024)

$347M

in federal SBIR/STTR grants secured by UNC startups

(Since 1958)

0%

of total UNC IP-based startups have worked in life sciences

Success Stories

Single-cell solution

Cell Microsystems, a company with UNC-Chapel Hill origins, is leapfrogging traditional technologies for single-cell cloning, culturing, analysis and isolation.

Read Story

A birth control pill for men

Eppin Pharma Inc. is developing a non-hormonal oral male contraceptive pill that has the potential to ease the economic, social and personal toll of unplanned pregnancies, bringing greater equity and flexibility to family planning.

Read Story

Brightening the odds for pancreatic cancer

Focal Medical's implantable technology uses an electrical field to deliver drugs in higher concentrations to hard-to-reach tumor cells.

Read Story

Innovate Carolina Impact Dashboard Data Sources: Innovate Carolina Startups Database, UNC Office of Technology Commercialization, Association of University Technology Managers; UNC startups employment data (most recent analysis FY 2024) © 2022 Innovate Carolina All Rights Reserved